Entera Bio Ltd — Quarterly Financial Statistics (NASDAQ:ENTX)

Financials

Cash from operating activities 2.15 M1.47 M1.4 M1.63 M2.5 M 7 M Cash from investing activities 03 0008 00029 K43 K 83 K Cash from financing activities 13 K3.22 M13.34 M-51 K250 K 16.75 M Free cash flow 2.15 M1.46 M1.4 M1.6 M2.46 M 6.92 M

新闻

What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)

Opko Health stock rating reiterated at Buy by H.C. Wainwright

エンテラ・バイオ、ジーノ・ジェルマーノを取締役会会長に任命

Entera Bio appoints Geno Germano as board chairman

OPKOとEnteraが副甲状腺機能低下症治療のための経口PTH開発で提携拡大

OPKO and Entera expand collaboration to develop oral PTH treatment

エンテラ・バイオ、骨粗鬆症薬の FDA 提出を2026年第1四半期に計画

Entera Bio plans FDA submission for osteoporosis drug in Q1 2026

H.C.ワインライト、FDAがBMDエンドポイントを認定したことでEntera Bio株の買い推奨を維持

H.C. Wainwright reiterates Buy rating on Entera Bio stock as FDA qualifies BMD endpoint

エンテラ・バイオの経口PTHアナログが持続的なカルシウム反応を示す

Entera Bio’s oral PTH analog shows sustained calcium response